Challenges involved in rolling out covid19 vaccines across the country. They will also discuss the opportunities for the Biden Harris Administration to deliver a rapid coordinated response to covid19, that includes strategic use of vaccines to protect more people. The speakers will bring a sciencebased perspective on these and other topics. Please note participants are welcome to use images, video, and quotes readily from the webcast and the content is for immediate relief. Release. I would like to briefly introduce our two speakers. Dr. Chris beyrer is the director for human health and public rights in the department of epidemiology, International Health and Health Behavior and society at the Johns Hopkins Bloomberg School of Public Health and also the founding director of the center for Public Health and human rights. During the pandemic, dr. Beyrer has been engaged in research and focusing on lessening prisons to prevent the spread of covid19, transmission of covid19 and efficacy of
Clerk on a motion to not disclose the closed session deliberations [roll call] clerk mr. Chair, there are three ayes. Chair mar thank you, mr. Clerk. Is there any further business . Clerk that concludes our business for today. Chair mar great. We are adjourned. Take care. Good morning. The meeting will come to order. The december 3rd meeting. I am joined by Committee Member peskin. Committee member haney will be joining us. I would like to thank sfgovtv for staffing this. Do you have announcements. In order to protect the public and City Employees during the Health Emergency the board of supervisors legislative chamber and Committee Room are closed. This is taken pursuant to local state and federal orders and directives. Committee members will attend through video and participate to the same extent as if physically present. Public comment is available for each item on the agenda. Both cable channel 26 and sfgovtv are streaming the call in number on your screen. Your opportunity to spea
Out covid19 vaccines across the country. They will also discuss the opportunities for the Biden Harris Administration to deliver a rapid coordinated response to covid19, that includes strategic use of vaccines to protect more people. The speakers will bring a sciencebased perspective on these and other topics. Please note participants are welcome to use images, video, and quotes readily from the webcast and the content is for immediate relief. Release. I would like to briefly introduce our two speakers. Dr. Chris beyrer is the director for human health and public rights in the department of epidemiology, International Health and Health Behavior and society at the Johns Hopkins Bloomberg School of Public Health and also the founding director of the center for Public Health and human rights. During the pandemic, dr. Beyrer has been engaged in research and focusing on lessening prisons to prevent the spread of covid19, transmission of covid19 and efficacy of mask wearing, as well as the d
Months. I was proud. We were doing well. Almost everyone in the city did what they asked you to do we are seeing how fast it could move the governor laid out a warning and we are seeing what is happening in San Francisco. Let me be clear, as clear as i can be, its not good. Cases are spiking. Hospitalizations are increasing quickly. Our infection rate is higher than the summer. This is not just about San Francisco but the entire region, state, and country the dangerous winter has arrived. We will have to take more action. We are still working out the details we are working out the details in Santa Santa Clara county. They have limited gatherings. Theres are things you have consider as well as other ideas to stop the spread. No one would like to be here. We spoke about worrying about doing well but having everyone relax and the cases spike like they did during the spanish flu. Im not saying thats what happened but there have been a lot of challenges including lack of national leadership
Happened with astrazeneca, what is your best estimate for when a safe vaccine will be available . Dr. Redfield one thing i have learned is the cdc director, i business. The opinion im in the data and signs of it. What does the data and signs suggest . Dr. Redfield based on enrollment right now that is going on with the pfizer and moderna, that it is conceptual that they will have enough data to present it to the fda for evaluation somewhere before the end of october and the end of november. The reason i cannot be more specific is because these trials are event driven trials. They are 100 dependent on how much covid occurs in the volunteer population. If it is a lot of these individuals having to get covid independent of what group they are in, and the potential for them to have enough events if the vaccine is very efficacious will be in the october timeframe. If the vaccine is 50 efficacious, it might be in the late november timeframe. If there are fewer events and it vaccine, andd mig